Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frontotemporal mild cognitive impairment.

Alexandre de Mendonça1, Filipa Ribeiro, Manuela Guerreiro

  • 1Dementia Clinics, Neurology Department, Institute of Molecular Medicine and Faculty of Medicine of Lisbon, Av. Prof. Egas Moniz, 1649-028 Lisbon, Portugal. mendonca@neurociencias.pt

Journal of Alzheimer'S Disease : JAD
|March 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

XPM Ultrafast Nanoindentation for Direct-Writing Lithography of SERS-Active Nanostructured Metallic Photonic Crystals: An Exploration from Instrumental Matters to Application Prospects.

The journal of physical chemistry letters·2026
Same author

Horizontal visibility graph analysis of melodic skylines in musical stimuli used in epilepsy research.

Chaos (Woodbury, N.Y.)·2026
Same author

Impact of Annealing on Perpendicular Magnetic Anisotropy and Interfacial Diffusion in Ultrathin [CoFeB/Pd]×n Multilayer Film.

Nanomaterials (Basel, Switzerland)·2026
Same author

Predicting progression from subjective cognitive decline to dementia using different neuropsychological criteria: A longitudinal study.

Archives of gerontology and geriatrics·2026
Same author

Peripheral microRNA signature in genetic frontotemporal dementia-findings from the GENFI initiative.

GeroScience·2026

Identifying frontotemporal mild cognitive impairment (FT-MCI) is possible using specific criteria. These criteria identify patients likely to progress to frontotemporal dementia, aiding early detection and intervention.

Area of Science:

  • Neurology
  • Neuroscience
  • Cognitive Science

Background:

  • Mild Cognitive Impairment (MCI) is a heterogeneous condition, potentially representing early stages of various neurological disorders.
  • Frontotemporal Dementia (FTD) is a common neurodegenerative disease with gradual onset, suggesting early detection may be feasible.

Observation:

  • A set of criteria for frontotemporal MCI (FT-MCI) was developed and applied retrospectively.
  • Seven patients met the FT-MCI criteria, exhibiting behavioral changes like apathy, disinhibition, and impaired decision-making for over a year.
  • Neuroimaging showed frontotemporal atrophy in most, and neuropsychological tests indicated frontal lobe deficits, yet patients maintained daily activities.

Findings:

  • All identified FT-MCI patients, except one, progressed to definite FTD within approximately 1.8 years.

Related Experiment Videos

  • The proposed criteria successfully identified a cohort at high risk for developing FTD.

    • Implications:

    • The developed criteria can aid in identifying individuals in the early stages of FTD.
    • Early identification of FT-MCI may facilitate timely therapeutic strategies and improve patient management.
    • This research contributes to understanding the preclinical and prodromal phases of frontotemporal dementia.